Start here if you're new
what it is
Philip Morris sells cigarettes and newer nicotine products outside the U.S. across 100 markets.
how it gets paid
Last year Philip Morris Int made $40.6B in revenue. Europe was the main engine at $16.2B, or 40% of sales.
why it's growing
Revenue grew 7.3% last year. The combustibles division posted a decent showing, with revenues up 4% thanks to higher pricing, partially offset by an unfavorable product mix.
what just happened
Philip Morris beat estimates with $1.69 in profit per share, above $1.66 expected.
At a glance
A+ balance sheet — rock-solid finances — built to survive anything
100/100 earnings predictability — you can trust these numbers
21.6x trailing p/e — priced about right
3.5% dividend yield — cash in your pocket every quarter
51.0% return on capital — a money-printing machine
xvary composite: 72/100 — average
What they do
Philip Morris sells cigarettes and newer nicotine products outside the U.S. across 100 markets.
You are buying 83,100 employees, 51 factories, and 100 markets that keep the machine running for your dividend. Old nicotine still pays, but 41% of Q3 revenue already came from smoke-free products. That mix is why a tobacco company can still print a 44.5% operating margin.
How they make money
$40.6B
annual revenue · their business grew +7.3% last year
Europe
$16.2B
South and Southeast Asia, Middle East, and Africa
$12.2B
East Asia, Australia, and PMI
$6.9B
Americas
$4.9B
Wellness and Healthcare
$0.4B
The products that matter
manufactures and sells cigarettes
Combustibles
~$24B FY · ~59% if smoke-free is ~41%
On ~$40.6B FY revenue, ~41% smoke-free (Q3 mix cited on this page) leaves ~59% for combustibles—about ~$24B, not $32.5B stacked on the same total. The hook’s 41% is a quarter mix; FY shares differ slightly.
cash engine
heated tobacco and oral nicotine
Smoke-Free Products
41% of revenue · 100 markets
this is the growth story the market is paying for. smoke-free accounted for 41% of revenue last quarter, and IQOS, ZYN, and VEEV were available in 100 markets as of mid-october.
transition engine
other reported revenue lines
Other reported segments
wellness & other · see filing
Geographic rows above foot to ~$40.6B; product splits (combustibles vs smoke-free) are a different cut. Use the 10-K segment tables—do not add a stray “$6.1B other” to the same bridge without a line-item match.
thin disclosure
Key numbers
44.5%
operating margin
Operating margin → profit left after running the business → 44.5 cents of each sales dollar stays with you.
51.0%
return on capital
Return on capital → profit made from money invested → 51 cents of operating profit for each dollar tied up.
3.5%
dividend yield
Dividend yield → cash income on the share price → you get $3.50 a year for every $100 you own at $161.94.
21.6x
trailing p/e
Trailing P/E → price paid for last year's profit → you are paying $21.60 for $1 of earnings.
Financial health
A+
strength
- balance sheet grade A+ — near the highest rating possible
- risk rank 1 — safer than 95% of stocks
- price stability 90 / 100
- net profit margin 30.0% — keeps 30 cents of every dollar in revenue
A+ with balance sheet grade and risk rank standing out. your money faces less risk here than at most public companies.
Total return vs. market
You invested $10,000 in PM 3 years ago → it's now worth $18,390.
The index would have given you $13,920.
source: institutional data · total return
What just happened
beat estimates
Philip Morris beat estimates with $1.69 in profit per share, above $1.66 expected.
Sales were $10.85B, about $150M above estimate, and 9% higher than a year earlier. Smoke-free products were 41% of revenue and were available in 100 markets.
$10.85B
quarter sales
$1.69
profit per share
67.6%
gross margin
smoke-free mix
41% of revenue came from smoke-free products. That matters because the pivot is now almost half the quarter, not a side hustle.
-
philip morris international reported better-than-expected 2025 third-quarter results.
-
revenues of $10.85 billion were nearly $150 million above our estimate and increased 9% compared to the previous-year tally.
-
the advance was driven by strong growth in the smoke-free business, which accounted for 41% of total revenues for the period.that group has been benefiting from robust demand for its three flagship brands: iqos, zyn, and veev.
-
as of mid-october, these three products were available for sale in 100 markets.
-
the combustibles division posted a decent showing, with revenues up 4% thanks to higher pricing, partially offset by an unfavorable product mix.
source: company earnings report, 2025
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is regulatory pressure on cigarettes and smoke-free nicotine at the same time.
med
combustibles fund the whole transition
The legacy cigarette business is still the cash engine, shown here as $32.5B in reported revenue. Higher excise taxes, flavor restrictions, or packaging rules hit the part of the company still paying the bills.
If regulation compresses that cash pool, Philip Morris has less room to fund buybacks, dividends, and smoke-free expansion at the same time.
med
41% smoke-free mix still has to keep climbing
Smoke-free already accounts for 41% of revenue, which is exactly why expectations rose. A transition story stops being exciting the moment the mix stops moving.
If IQOS, ZYN, and VEEV adoption slows, the stock can lose its transition premium and trade more like a mature yield vehicle.
med
the regulatory map is expanding with the footprint
IQOS, ZYN, and VEEV were available in 100 markets as of mid-october. That broadens opportunity, but it also multiplies the number of regulators, tax regimes, and product rules that can change the economics.
A forced product change or market restriction does not just hit one launch. It can ripple through the global rollout story the market is underwriting.
the company is trying to protect a 29.2% net margin while moving 41% of revenue into smoke-free. Any policy shock that hurts the old cash engine or the new growth engine lands directly on that balancing act.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
smoke-free mix
41% of revenue now comes from smoke-free products. If that number keeps rising, the thesis is intact. If it stalls, the multiple is exposed.
risk
combustibles pricing power
Combustibles posted 4% revenue growth from pricing. You want to see the old business keep funding the new one, not fade faster than price can offset.
calendar
next earnings check-in
Watch whether quarterly revenue holds near the current $10.8B level and whether management keeps talking about smoke-free as a growth engine instead of a future ambition.
trend
market expansion
IQOS, ZYN, and VEEV were in 100 markets as of mid-october. More markets help, but only if adoption follows the footprint.
Analyst rankings
short-term outlook
below average
momentum score 4 — in human-speak, analysts think the stock may lag from here even if the business stays stable.
risk profile
safest 5%
stability score 1 — lower risk of permanent capital loss than most stocks in the market.
chart momentum
average
technical score 3 — no dramatic signal here. You are buying the business model, not a chart breakout.
earnings predictability
100 / 100
management usually lands close to guidance. For you, that means fewer nasty surprises and a cleaner underwriting case.
source: institutional data
Institutional activity
1,213 buyers vs. 1,225 sellers in 3q2025. total institutional holdings: 1.3B shares.
source: institutional data
Price targets
3-5 year target range
$129
$227
$162
current price
$178
target midpoint · +10% from current · 3-5yr high: $220 (+35% · 11% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive